Luminescence imaging in biomedical research has allowed new insights into the
architecture of pathological tissues, signalling networks and cell interactions, and is now …

Biomedical fluorescence imaging in the second near-infrared (NIR-II, 100–1700 nm) window
provides great potential for visualizing physiological and pathological processes, owing to …

Strong fluorescence and high catalytic activities cannot be achieved simultaneously due to
conflicts in free electron utilization, resulting in a lack of bioactivity of most near-infrared-II …

Visualizing biomolecules such as enzymes in the deep tissue of living organisms via
molecular ratiometric fluorescent probes in the second near-infrared window (NIR-II) with a …

In vivo imaging technologies have emerged as a powerful tool for both fundamental
research and clinical practice. In particular, luminescence imaging in the tissue-transparent …

NIR-II imaging is developed rapidly for noninvasive deep tissue inspection with high spatio-
temporal resolution, taking advantage of diminished autofluorescence and light attenuation …

The renal-clearable aspect of imaging agent with minimum toxicity issues and side effects is
essential for clinical translation, yet clinical near-infrared-I/II (NIR-I/II) fluorophores with timely …

Bone defects are encountered substantially in clinical practice, and bionic scaffolds
represent a promising solution for repairing bone defects. However, it is difficult to fabricate …

Fluorescence imaging in the second near-infrared biological window (NIR-II, 1000–1700
nm) presents unparalleled merits of non-invasion, high sensitivity, deeper penetration depth …

Early diagnosis of allograft rejection helps to improve the immune‐related management of
transplant recipients. The clinically‐used core needle biopsy method is invasive and subject …